Indications and limitations of third-generation aromatase inhibitors

Lonning

Expert. Opin. Invest. Drugs, (5) 2008

Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study.

Geisler J, Haynes B, Anker G, Dowsett M, Lonning PE

J Clin Oncol, (3):751-757 2002

MED: 11821457

In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients.

Geisler J, King N, Anker G, Ornati G, Di Salle E, Lonning PE, Dowsett M

Clin Cancer Res, (9):2089-2093 1998

MED: 9748124

Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer.

Geisler J, Detre S, Berntsen H, Ottestad L, Lindtjorn B, Dowsett M, Einstein Lonning P

Clin Cancer Res, (5):1230-1236 2001

MED: 11350888

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, [...] Boyle WJ

Cell, (2):165-176 1998

MED: 9568710

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T

Proc Natl Acad Sci U S A, (7):3597-3602 1998

MED: 9520411

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.

Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Elliott R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, [...] Boyle WJ

Proc Natl Acad Sci U S A, (7):3540-3545 1999

MED: 10097072

Role of RANK ligand in mediating increased bone resorption in early postmenopausal women.

Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL

J Clin Invest, (8):1221-1230 2003

MED: 12697741

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, [...] Boyle WJ

Cell, (2):309-319 1997

MED: 9108485

Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands.

Horowitz MC, Xi Y, Wilson K, Kacena MA

Cytokine Growth Factor Rev, (1):9-18 2001

MED: 11312114